Concepedia

Xianling Wang

XW

Statistics

Publications

2

Citations

108

H-Index

2

Active since

2006

Affiliations

Bristol-Myers Squibb (United States)(Current)

Xianling Wang is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, thrombosis pathophysiology, and thrombosis mechanisms.

ORCID

Publications per year

2006–2024

2

Publications

2

Murine model of ferric chloride‐induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor

Xianling Wang, Patricia L. Smith, Mei-Yin Hsu et al. · Journal of Thrombosis and Haemostasis · 2006 · 94 citations · Full text

, , +12

Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies

Jason J. Luke, Karen A. Gelmon, Lillian L. Siu et al. · Clinical Cancer Research · 2024 · 14 citations

, , +17

1–2 of 2